Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Volker Schibgilla"'
Autor:
Stefan G, Spitzer, Petra, Wacker, Steffen, Gazarek, Klaus, Malinowski, Volker, Schibgilla, Andreas, Hitzler
Publikováno v:
Pacing and Clinical Electrophysiology. 32:1553-1561
Introduction: PASTA (pacing of the atria in sinus node disease) is a prospective and randomized trial, assessing the effect of different atrial lead positions on the atrial fibrillation (AF) incidence in patients with sinus node disease (SND). Method
Autor:
Nathan M Segerson, Guido Ritscher, Georg Noelker, Harald Rittger, Nassir F. Marrouche, Martin Schmidt, Harald Marschang, Jens Guenther, Marcos Daccarett, Volker Schibgilla, Johannes Brachmann
Publikováno v:
Journal of Cardiovascular Electrophysiology. 18:583-588
INTRODUCTION We performed a prospective study to compare efficacy and safety of both open irrigation tip (OIT) technology with intracardiac echo (ICE)-guided energy delivery in patients presenting for PVAI. METHODS AND RESULTS Fifty-three patients pr
Autor:
Christoph Stellbrink, Peter Hanrath, Frank Birkenhauer, Jörg O. Schwab, Rainer Schimpf, Johannes Brachmann, Anil-Martin Sinha, Volker Schibgilla, Ole A. Breithardt
Publikováno v:
International Journal of Cardiology. 114:323-331
Background Inappropriate therapy for supraventricular tachyarrhythmia is still a major problem in implantable cardioverter defibrillators (ICD). The morphology discrimination algorithm compares the morphology of a tachycardia electrogram with a store
Publikováno v:
Pacing and Clinical Electrophysiology. 26:268-271
This study examines the effects of various atrial lead positions in physiological pacing on the incidence of AF in patients with sick sinus syndrome. The lead is implanted in the RA free wall, in the RA appendage, near the coronary sinus ostium (CSO)
Publikováno v:
Herzschrittmachertherapie und Elektrophysiologie. 12:103-108
Hintergrund Steroideluierende Elektroden weisen im Vergleich zu herkommlichen Elektroden nur einen geringen initialen Reizschwellenanstieg auf. Eine Reduktion der chronischen Reizschwelle und damit eine Verlangerung der Batterielebensdauer durch eine
Publikováno v:
Zeitschrift f�r Kardiologie. 87:640-643
Wir berichten uber den Fall einer 56jahrigen Patientin mit einem ICD-System Typ Ventak AV (CPI), implantiert nach mehrfacher Reanimation bei Kammerflimmern und vorbestehendem, intermittierendem AV-Block III°. Bei ventrikularer Extrasystolie kam es w
Publikováno v:
Herzschrittmachertherapie und Elektrophysiologie. 9:127-133
AV-synchrone Zweikammerstimulation und Frequenzadaptation bei chronotrop inkompetenten Patienten sind als wesentliche Faktoren zur Steigerung der maximalen Belastbarkeit hinreichend bekannt. Ihre Bedeutung im Rahmen einer submaximalen Belastung ist h
Autor:
Stephan Achenbach, Björn Diem, Werner Moshage, Tobias Bieberlea, Volker Schibgilla, Kurt Bachmann
Publikováno v:
American Heart Journal. 134:467-473
In phantom studies we investigated the effects of magnetic resonance imaging (MRI) on pacemakers and electrodes. Twenty-five electrodes were exposed to MRI in a 1.5T scanner with continuous registration of the temperature at the electrode tip. Eleven
Publikováno v:
Herzschrittmachertherapie und Elektrophysiologie. 8:124-128
The use of GSM or D-net mobile-phones has been proven to disturb antibradycardiac pacemaker function by electromagnetic fields. Therefore interference between these phones and subpectroral ICD-systems is conceivable. We investigated effects on progra
Autor:
Michel Haïssaguerre, Andrea Natale, Aldo Bonso, Antonio Raviele, Oussama M. Wazni, Randall C. Starling, Jennifer E. Cummings, Amin Al-Ahmad, David O. Martin, Raffaele Fanelli, Paul J. Wang, Pierre Jaïs, Johannes Brachmann, Prashanthan Sanders, Salwa Beheiry, Volker Schibgilla, Steven Hao, Domenico Potenza, Josef Kautzner, Gemma Pelargonio, Luigi Di Biase, Antonio Dello Russo, Sakis Themistoclakis, Raimondo Massaro, Pietro Santarelli, Mohammed N. Khan, Michela Casella, Walid Saliba, Robert A. Schweikert
Publikováno v:
The New England journal of medicine. 359(17)
Pulmonary-vein isolation is increasingly being used to treat atrial fibrillation in patients with heart failure.In this prospective, multicenter clinical trial, we randomly assigned patients with symptomatic, drug-resistant atrial fibrillation, an ej